DAWN CERVANTES: Open Payments
NPI 1497241459 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 56 payments from 18 companies in 2025. Trend: 2023 $932 · 2024 $1,101 · 2025 $1,497
Food & beverage: $1,412Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $384 |
| LEO Pharma Inc. | 8 | $321 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $130 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Lilly USA, LLC | 3 | $80 |
| GENZYME CORPORATION | 3 | $73 |
| Amgen Inc. | 3 | $69 |
| Janssen Biotech, Inc. | 2 | $66 |
| UCB, Inc. | 1 | $42 |
| PFIZER INC. | 2 | $36 |
Products named: RINVOQ, ADBRY, SKYRIZI, ANZUPGO, DUPIXENT, OTEZLA, TREMFYA, COSENTYX.
Industry payments across FL — which companies pay providers there.
